This highlights the unique immune environment of thymomas, characterized by thymic epithelial disruption and autoimmunity links, differing from PD-L1-dominant evasion in lung cancer or B cell dysregulation in lymphoma[21–23]. Here, CD274 is linked to lung cancer.